| Primary |
| Hypertension |
62.8% |
| Blood Pressure Increased |
6.2% |
| Drug Exposure During Pregnancy |
5.5% |
| Essential Hypertension |
4.8% |
| Blood Pressure Abnormal |
3.4% |
| Suicide Attempt |
2.8% |
| Product Used For Unknown Indication |
2.1% |
| Renal Cell Carcinoma Stage Unspecified |
2.1% |
| Blood Cholesterol Increased |
1.4% |
| Diabetes Mellitus |
1.4% |
| General Anaesthesia |
1.4% |
| Pregnancy Induced Hypertension |
1.4% |
| Gestational Hypertension |
0.7% |
| Pre-eclampsia |
0.7% |
| Prehypertension |
0.7% |
| Prophylaxis |
0.7% |
| Renal Cell Carcinoma |
0.7% |
| Thyroid Disorder |
0.7% |
| Uterine Contractions During Pregnancy |
0.7% |
|
| Drug Exposure During Pregnancy |
16.7% |
| Small For Dates Baby |
10.4% |
| Hypertension |
8.3% |
| Respiratory Failure |
8.3% |
| Drug Screen False Positive |
4.2% |
| Low Birth Weight Baby |
4.2% |
| Malaise |
4.2% |
| Maternal Exposure During Pregnancy |
4.2% |
| Platelet Count Increased |
4.2% |
| Premature Baby |
4.2% |
| Premature Labour |
4.2% |
| Restlessness |
4.2% |
| Somnolence |
4.2% |
| Toxic Skin Eruption |
4.2% |
| Ultrasound Antenatal Screen Abnormal |
4.2% |
| Abdominal Pain |
2.1% |
| Anaemia Haemolytic Autoimmune |
2.1% |
| Aspartate Aminotransferase Increased |
2.1% |
| Bradycardia Foetal |
2.1% |
| Caesarean Section |
2.1% |
|
| Secondary |
| Hypertension |
38.9% |
| Product Used For Unknown Indication |
9.6% |
| Drug Use For Unknown Indication |
7.5% |
| Suicide Attempt |
7.4% |
| Essential Hypertension |
6.8% |
| Hiv Infection |
3.7% |
| Drug Exposure During Pregnancy |
2.6% |
| Intentional Overdose |
2.6% |
| Maternal Exposure Timing Unspecified |
2.5% |
| Pre-eclampsia |
2.5% |
| Renal Transplant |
2.5% |
| Anaesthesia |
1.9% |
| Blood Pressure Increased |
1.8% |
| Epilepsy |
1.8% |
| Prophylaxis |
1.6% |
| Foetal Exposure Timing Unspecified |
1.4% |
| Infertility Female |
1.4% |
| Arrhythmia |
1.2% |
| Ill-defined Disorder |
1.2% |
| Psoriasis |
1.2% |
|
| Premature Baby |
19.1% |
| Suicide Attempt |
8.7% |
| Maternal Exposure During Pregnancy |
7.8% |
| Premature Labour |
7.8% |
| Drug Exposure During Pregnancy |
5.2% |
| Foetal Exposure During Pregnancy |
5.2% |
| Maternal Drugs Affecting Foetus |
5.2% |
| Vomiting |
5.2% |
| Hypoglycaemia |
4.3% |
| Premature Delivery |
3.5% |
| Small For Dates Baby |
3.5% |
| Talipes |
3.5% |
| Urinary Tract Infection |
3.5% |
| Polydactyly |
2.6% |
| Proteinuria |
2.6% |
| Renal Failure Acute |
2.6% |
| Therapy Non-responder |
2.6% |
| Urethral Obstruction |
2.6% |
| Vaginal Haemorrhage |
2.6% |
| Cholecystitis |
1.7% |
|
| Concomitant |
| Hypertension |
30.2% |
| Product Used For Unknown Indication |
19.3% |
| Drug Use For Unknown Indication |
10.3% |
| Rheumatoid Arthritis |
4.9% |
| Diabetes Mellitus |
4.8% |
| Type 2 Diabetes Mellitus |
4.0% |
| Asthma |
3.3% |
| Blood Pressure |
3.2% |
| Depression |
3.0% |
| Hiv Infection |
2.5% |
| Pain |
2.4% |
| Diffuse Large B-cell Lymphoma |
2.0% |
| Hyperlipidaemia |
1.5% |
| Lip And/or Oral Cavity Cancer |
1.3% |
| Hypothyroidism |
1.3% |
| Nausea |
1.2% |
| Contraception |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Prophylaxis |
1.2% |
| Cough |
1.1% |
|
| Premature Baby |
11.1% |
| Vomiting |
7.4% |
| Hypertension |
7.0% |
| Drug Exposure During Pregnancy |
6.7% |
| Renal Failure Acute |
6.7% |
| Androgenetic Alopecia |
5.9% |
| Pregnancy |
5.9% |
| Weight Decreased |
5.6% |
| Nausea |
5.2% |
| Maternal Exposure During Pregnancy |
4.4% |
| Abortion Spontaneous |
3.7% |
| Pneumonia |
3.7% |
| Urine Oxalate Increased |
3.7% |
| Death |
3.3% |
| Drug Ineffective |
3.3% |
| Renal Impairment |
3.3% |
| Sinusitis Fungal |
3.3% |
| Somnolence |
3.3% |
| Therapeutic Response Decreased |
3.3% |
| Cerebrovascular Accident |
3.0% |
|
| Interacting |
| Hypertension |
33.3% |
| Benign Prostatic Hyperplasia |
20.0% |
| Overdose |
10.0% |
| Pollakiuria |
6.7% |
| Bacterial Infection |
3.3% |
| Cardiac Failure |
3.3% |
| Dementia |
3.3% |
| Hypothyroidism |
3.3% |
| Ischaemic Heart Disease Prophylaxis |
3.3% |
| Nephritis |
3.3% |
| Schizophrenia |
3.3% |
| Schizophrenia, Paranoid Type |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
|
| Surgery |
33.3% |
| Dehydration |
16.7% |
| Drug Interaction |
16.7% |
| Retrognathia |
16.7% |
| Vomiting |
16.7% |
|
